ComplianceOnline

New Institute of Medicine Study Proposes Scrapping of FDA’s 510(k) Submission Process

  • By: Staff Editor
  • Date: August 19, 2011
Webinar All Access Pass Subscription Abstract:

The Institute of Medicine has released a report that has found the FDA’s existing rules for the 510(k) clearance lacks the legal basis to be a reliable premarket screen of the safety and effectiveness.

The report has been criticized by the medical device industry while patient rights groups have welcomed its findings.

Bookmark and Share

Compliance Trainings

Compliance Standards

Best Sellers
You Recently Viewed
    Loading